• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE; CLAMP, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE; CLAMP, VASCULAR Back to Search Results
Model Number ICF100
Device Problem Hole In Material (1293)
Patient Problem Not Applicable (3189)
Event Date 04/26/2018
Event Type  malfunction  
Manufacturer Narrative
The subject device is not available for evaluation as it was discarded by the hospital staff.The clinical observation was unable to be confirmed.A definitive root cause cannot be determined as this time.The instructions for use (ifu) has been reviewed and no inadequacies were identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The ifu provides the following warnings and cautions: "check the balloon prior to insertion to ensure that a vacuum has been maintained.A loss of balloon vacuum indicates that there is a leak in the system which may result in unexpected balloon deflation and loss of aortic occlusion.If a leak is detected, replace the intraclude device or leaking component prior to use.Always wet the balloon surface with sterile physiologic solution prior to insertion to facilitate intraclude device introduction through the hemostasis valve or damage to the intraclude device may occur.A loss of occlusion (evident by blood in the surgical field and/or a rise in aortic root pressure) along with a significant loss of pressure within the balloon may indicate compromised balloon integrity.Completely deflate the balloon and remove the intraclude device carefully according to the withdrawal instructions to reduce the risk of patient injury.Do not add volume to the balloon based on a gradual balloon pressure drop as bursting of the balloon can occur.A gradual balloon pressure drop is normal, due to material relaxation of the balloon, and does not indicate loss of occlusion in the aorta." edwards will continue to review and monitor all events through the use of edwards quality systems.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No further corrective or preventative actions are required at this time.
 
Event Description
Edwards received information that the customer experience a drop of balloon pressure with balloon rupture during a mvr case.The subject device was prepared without any abnormalities noted.Thirty six milliliters of volume was added to the balloon initially.Then another 14 ml was added throughout the case.A gradual drop of pressure was noted; however, faster than normal.Immediately, the surgeon occluded the aorta with a chitwood clamp without sternotomy to complete the case.The patient developed transient ischemic attack (tia) postoperatively.The patient later expired.Per the surgeon, the tia was not related to the issues experienced on the subject device.The surgeon and the surgical staff disassociate the final outcome from the subject device.
 
Manufacturer Narrative
The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Per the engineering evaluation, a manufacturing defect was not confirmed.As reported, 36 ml of volume were added to the balloon initially and another 14 ml were added throughout the case, exceeding the maximum recommended volume.This may have caused or contributed to the reported balloon rupture; however, the device was not returned and a definitive root cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE
Type of Device
CLAMP, VASCULAR
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
Manufacturer Contact
neil landry
one edwards way
mle2
irvine, CA 92614
9492502289
MDR Report Key7530437
MDR Text Key109064500
Report Number3008500478-2018-00069
Device Sequence Number1
Product Code DXC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K163693
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/07/2019
Device Model NumberICF100
Device Catalogue NumberICF100
Device Lot Number61184967
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/26/2018
Initial Date FDA Received05/21/2018
Supplement Dates Manufacturer Received06/19/2018
Supplement Dates FDA Received06/22/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-